J Bacteriol Virol.  2012 Dec;42(4):330-338. 10.4167/jbv.2012.42.4.330.

Generation and Biological Characterization of a Neutralization-Resistant Mutant of Newcastle Disease Virus

  • 1OIE Reference Laboratory for Newcastle Disease, Animal, Plant and Fisheries Quarantine and Inspection Agency, Anyang, Korea.
  • 2Avian Diseases Division, Animal, Plant and Fisheries Quarantine and Inspection Agency, Anyang, Korea. kchoi0608@korea.kr


A neutralization-resistant mutant of Newcastle disease virus (NDV) Kr005 strain belonging to class II genotype VII was generated using a neutralizing monoclonal antibody and its biological effects were assessed. The mutant showed single amino acid substitution (E to K) at position 347 of the hemagglutinin-neuraminidase (HN) protein (E347K mutant). The E347K mutant exhibited marked rounding of the cells and few syncytia in infected chicken embryofibroblast (CEF) cells. The hemadsorption and neuraminidase activities of the E347K mutant of the wild-type virus were 118% and 166%, respectively. The mutant produced a rapid elution pattern whereas the wild type had a slow elution pattern. Growth kinetics studies showed that the E347K mutant produced an 80-times higher yield of extracellular virus in CEF cells compared with the wild-type virus. The time-course virus titer showed a marked increase in mutant-infected cells from 6 h to 12 h post infection (pi), which was consistent with the titer pattern time-course for NA activity. The E347K mutant virus showed a slight decrease in virulence compared to the wild-type virus, but there was no change in pathotype when measured by in vivo pathogenicity testing. These results suggest that an E347K mutation in HN protein might be associated with increased NA activity and subsequent enhancement of virus release from infected cells without change in viral pathotype.


Newcastle disease virus; HN protein; Neuraminidase activity; Neutralization resistant escape mutant
Full Text Links
  • JBV
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr